Polyethylene glycol–polylactic acid nanoparticles modified with cysteine–arginine–glutamic acid–lysine–alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect

Polyethylene glycol–polylactic acid nanoparticles modified with cysteine–arginine–glutamic acid–lysine–alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect

Junzhu Wu,1,2,* Jingjing Zhao,1,3,* Bo Zhang,1 Yong Qian,1 Huile Gao,1 Yuan Yu,1 Yan Wei,1 Zhi Yang,1 Xinguo Jiang,1 Zhiqing Pang1 1Key Laboratory of Smart Drug Delivery, Ministry of Education, Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, 2School of Pharmacy, Dali U...

Full description

Saved in:
Bibliographic Details
Main Authors: Wu J, Zhao J, Zhang B, Qian Y, Gao H, Yu Y, Wei Y, Yang Z, Jiang X, Pang Z
Format: article
Language:EN
Published: Dove Medical Press 2014
Subjects:
Medicine (General)
R5-920
Online Access:https://doaj.org/article/10fa0f5d8a5a40bab1d5d5d3c13e4b16
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/10fa0f5d8a5a40bab1d5d5d3c13e4b16

Similar Items